Dr Jamie Morton
MBBS PhD FRACP FCSANZ
Cardiovascular Imaging Specialist
“I want to use my cardiac research and imaging expertise to deliver the best treatment for patients.”
Special clinical interest in non invasive cardiac imaging and cardiac pharmaceutical research.
About Dr Jamie Morton
Dr Jamie Morton is a Cardiovascular Imaging Specialist with special clinical interest in non invasive cardiac imaging and cardiac pharmaceutical research. Dr Morton graduated from the University of Adelaide in 2001 and completed his internship at the Royal Adelaide Hospital. He then spent two years working in London, particularly at St Thomas’ Hospital. Upon returning to Australia, he finished his advanced cardiology training at the Royal Prince Alfred Hospital, Sydney, receiving a Distinguished Teacher Award in 2009. He was awarded his FRACP in 2010. In 2013, he completed his NHMRC funded PhD on the role “good cholesterol” plays in cardiovascular disease from the University of Sydney.
His research has been presented at national and international conferences and has received awards from the Cardiac Society of Australia and New Zealand, American Heart Association, and the Heart Research Institute.
He returned to Adelaide in 2013 to join Advara HeartCare where he developed his passion for cardiovascular imaging. He was instrumental in setting up the first cardiologist led, dedicated cardiac CT scanner in Adelaide. He is the head of Research (SA) and is principal investigator on several ongoing clinical pharmacological trials. His specialised interests are in echocardiography, CT coronary angiography and clinical research.
- 2010-2013 NHMRC funded PHD candidate, University of Sydney.
- 2013 Top rated abstract AHA ASM.
- 2012 Poster Prize CSANZ ASM.
- 2012 HRI Young Achiever Award for the Best Publication by a PhD Student.
- 2012 CSANZ ASM Travelling Fellow Scholarship.
- A. Baumann, J. Lushington, B. Pitman, J. Morton, M. Shirazi, M. Stokes, J. Edwards. A case of Left Ventricular Outflow Tract Pseudoaneurysm: An Incidental Finding Revealing Occult Infective Endocarditis.
- Cardiovascular Imaging Case Reports. 2020 J. Morton, S. Bao, L. Vanags, T. Tsatralis, A. Ridiandries, C. Siu, K. Ng, J. Tan, D. Celermajer, M. Ng, C. Bursill.
- Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early versus Late stage Atherosclerosis. JACC:Basic to Translational Science. 2018 (3):187-199. J. Morton, M. K. C. Ng, J. Chalmers, M. Woodward, G. Mancia, N. R. Poulter, M. Marre, M. Cooper, S. Zoungas.
- The associated of high density lipoprotein cholesterol with cancer incidence in type 2 diabetes: a case of reverse causality? Cancer Epidemiology, Biomarkers & Prevention. 2013 (9):1628-33 J.Morton, S. Zoungas, Q. Li, A. Patel, J. Chalmers, M. Woodward, D. Celermajer, J. Beulens, R. Stolk, P. Glasziou, M. Ng, Low HDL Cholesterlol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study. Diabetes Care. 2012;35 (11): 2201-6
- Fellow of the Royal Australasian College of Physicians
- Fellow of the Cardiac Society of Australia and New Zealand
- Fellow of the European Society of Cardiology
- CT Coronary angiogram specialist, level B